Usefulness of the Controlled Attenuation Parameter for Detecting Liver Steatosis in Health Checkup Examinees

키워드

참고문헌 (35)

1. Haque M, "The metabolic abnormalities associated with non-alcoholic fatty liver disease", Best Pract Res Clin Gastroenterol, 16, pp.709~731 (2002)
2. Harrison SA, "The natural history of nonalcoholic fatty liver disease: a clinical histopathological study", Am J Gastroenterol, 98, pp.2042~2047 (2003)
3. Fassio E, "Natural history of nonalcoholic steatohepatitis: a longitudinal study of repeat liver biopsies", Hepatology, 40, pp.820~826 (2004)
4. Adams LA, "The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies", J Hepatol, 42, pp.132~138 (2005)
5. Kim NH, "Non-alcoholic fatty liver disease, metabolic syndrome and subclinical cardiovascular changes in the general population", Heart, 100, pp.938~943 (2014)
6. Powell EE, "Metabolic factors and non-alcoholic fatty liver disease as co-factors in other liver diseases", Dig Dis, 28, pp.186~191 (2010)
7. Hübscher SG, "Histological assessment of non-alcoholic fatty liver disease", Histopathology, 49, pp.450~465 (2006)
8. Rockey DC, "Liver biopsy", Hepatology, 49, pp.1017~1044 (2009)
9. Myers RP, "Utilization rates, complications and costs of percutaneous liver biopsy: a population-based study including 4275 biopsies", Liver Int, 28, pp.705~712 (2008)
10. Dasarathy S, "Validity of real time ultrasound in the diagnosis of hepatic steatosis: a prospective study", J Hepatol, 51, pp.1061~1067 (2009)
11. Sasso M, "Controlled attenuation parameter (CAP): a novel VCTE(TM) guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes", Ultrasound Med Biol, 36, pp.1825~1835 (2010)
12. de Lédinghen V, "Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography", Liver Int, 32, pp.911~918 (2012)
13. Ratziu V, "A position statement on NAFLD", NASH based on the EASL 2009 special conference, 2010, pp.53, 372~384
14. Sasso M, "Novel controlled attenuation parameter for noninvasive assessment of steatosis using Fibroscan(®): validation in chronic hepatitis C", J Viral Hepat, 19, pp.244~253 (2012)
15. Myers RP, "Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography", Liver Int, 32, pp.902~910 (2012)
16. De Lorenzo A, "Assessment of body composition by bioelectrical impedance in adolescent patients with celiac disease", Am J Gastroenterol, 94, pp.2951~2955 (1999)
17. Nagaya T, "Body mass index (weight", height2) or percentage body fat by bioelectrical impedance analysis: which variable better reflects serum lipid profile?, 1999, pp.23, 771~774
18. Kobayashi J, "The relationship of percent body fat by bioelectrical impedance analysis with blood pressure, and glucose and lipid parameters", J Atheroscler Thromb, 13, pp.221~226 (2006)
19. Foster KJ, "The accuracy of ultrasound in the detection of fatty infiltration of the liver", Br J Radiol, 53, pp.440~442 (1980)
20. Kim HJ, "Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults", Arch Intern Med, 164, pp.2169~2175 (2004)
21. Chang Wook Chon, "Effect of Nonalcoholic Fatty Liver Disease on the Development of Type 2 Diabetes in Nonobese, Nondiabetic Korean Men", Gut and Liver, 6(3), pp.368~373 (2012), 거트앤리버 발행위원회[DOI]
22. Yun JW, "Abnormal glucose tolerance in young male patients with nonalcoholic fatty liver disease", Liver Int, 29, pp.525~529 (2009)
23. Choi JH, "Increased risk of type 2 diabetes in subjects with both elevated liver enzymes and ultrasonographically diagnosed nonalcoholic fatty liver disease: a 4-year longitudinal study", Arch Med Res, 44, pp.115~120 (2013)
24. Kim HC, "Association between nonalcoholic fatty liver disease and carotid intima-media thickness according to the presence of metabolic syndrome", Atherosclerosis, 204, pp.521~525 (2009)
25. Kim BJ, "The association between nonalcoholic fatty liver disease, metabolic syndrome and arterial stiffness in nondiabetic, nonhypertensive individuals", Cardiology, 123, pp.54~61 (2012)
26. Thakur ML, "Nonalcoholic fatty liver disease is associated with subclinical atherosclerosis independent of obesity and metabolic syndrome in Asian Indians", Atherosclerosis, 223, pp.507~511 (2012)
27. Sullivan S, "Randomized trial of exercise effect on intrahepatic triglyceride content and lipid kinetics in nonalcoholic fatty liver disease", Hepatology, 55, pp.1738~1745 (2012)
28. Wong VW, "Community-based lifestyle modification programme for non-alcoholic fatty liver disease: a randomized controlled trial", J Hepatol, 59, pp.536~542 (2013)
29. Hernaez R, "Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis", Hepatology, 54, pp.1082~1090 (2011)
30. Cardi M, "Superiority of laparoscopy compared to ultrasonography in diagnosis of widespread liver diseases", Dig Dis Sci, 42, pp.546~548 (1997)
31. Hepburn MJ, "The accuracy of the report of hepatic steatosis on ultrasonography in patients infected with hepatitis C in a clinical setting: a retrospective observational study", BMC Gastroenterol, 5, pp.14~ (2005)
32. Wieckowska A, "Diagnosis of nonalcoholic fatty liver disease: invasive versus noninvasive", Semin Liver Dis, 28, pp.386~395 (2008)
33. Adams LA, "Diagnostic evaluation of nonalcoholic fatty liver disease", J Clin Gastroenterol, 40(1), pp.S34~S38 (2006)
34. Rocha LA, "Specimen collection: an essential tool", Science, 344, pp.814~815 (2014)
35. Castera L, "Noninvasive evaluation of NAFLD", Nat Rev Gastroenterol Hepatol, 10, pp.666~675 (2013)

관련 논문AI추천